Detail akcie Quest Diagnostcs online

Business Summary: Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Quest Diagnostics Inc revenues increased 12% to $2.65B. Net income applicable to common stockholders increased 13% to $219M. Revenues reflect Diagnostic Information Services Business segment increase of 13% to $2.59B. Net income benefited from Diagnostic Information Services Business segment income increase of 11% to $414M, General corporate activities segment loss decrease of 7% to $76M.